Search hospitals > Rhode Island > Providence
Rhode Island Hospital
Claim this profileProvidence, Rhode Island 02903
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Solid Tumors
Conducts research for Leukemia
856 reported clinical trials
62 medical researchers
Summary
Rhode Island Hospital is a medical facility located in Providence, Rhode Island. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Solid Tumors, Leukemia and other specialties. Rhode Island Hospital is involved with conducting 856 clinical trials across 1,088 conditions. There are 62 research doctors associated with this hospital, such as Jennifer J. Welch, Bradley DeNardo, Benedito Carneiro, and Adam J. Olszewski.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Breast Cancer
Global LeaderHER2 positive
HER2 negative
ER positive
Top PIs
Jennifer J. WelchRhode Island Hospital8 years of reported clinical research
Expert in Brain Tumor
Expert in Cancer
45 reported clinical trials
107 drugs studied
Bradley DeNardoRhode Island Hospital3 years of reported clinical research
Studies Brain Tumor
Studies Cancer
27 reported clinical trials
75 drugs studied
Benedito CarneiroLifespan Cancer Institute3 years of reported clinical research
Studies Solid Tumors
Studies Cancer
11 reported clinical trials
21 drugs studied
Adam J. OlszewskiRhode Island Hospital4 years of reported clinical research
Studies Mantle Cell Lymphoma
Studies Lymphoma
11 reported clinical trials
25 drugs studied
Clinical Trials running at Rhode Island Hospital
Lung Cancer
Breast Cancer
Brain Tumor
Testicular cancer
Breast cancer
Wilms Tumor
Neuroblastoma
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Prostate Cancer
Focused Ultrasound + Immunotherapy
for Brain Cancer
The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier opening with Exablate Model 4000 Type 2.0/2.1 for the treatment of NSCLC brain metastases in patients who are undergoing planned FDA approved, on-label systemic therapy utilizing immune checkpoint inhibitors.
Recruiting3 awards Phase 3
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting2 awards Phase 37 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rhode Island Hospital?
Rhode Island Hospital is a medical facility located in Providence, Rhode Island. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Solid Tumors, Leukemia and other specialties. Rhode Island Hospital is involved with conducting 856 clinical trials across 1,088 conditions. There are 62 research doctors associated with this hospital, such as Jennifer J. Welch, Bradley DeNardo, Benedito Carneiro, and Adam J. Olszewski.
Where is Rhode Island Hospital located?
To reach Rhode Island Hospital in Providence, RI, take exit 20 from I-95 North and follow signs for Point Street. Turn left onto Friendship Street at the end of the ramp, then continue straight to 593 Eddy Street. Alternatively, GPS navigation services like MapQuest or Waze can provide real-time driving directions.
Who should I call to ask about financial aid or insurance network?
**Rhode Island Hospital Financial Assistance:**
- For financial assistance, contact the Patient Financial Advocacy Program at (401) 788-1383. Assistance is available for uninsured Rhode Island residents meeting income criteria.
- The Charity Care program aids uninsured, low-income residents who cannot access state, federal, or employer-sponsored health insurance.
**Insurance Inquiries:**
- For insurance questions or help understanding hospital bills, call customer service at 1-800-884-6966.
What insurance does Rhode Island Hospital accept?
Rhode Island Hospital accepts a wide range of insurance plans, including but not limited to Aetna, Blue Cross Blue Shield of Rhode Island, Harvard Pilgrim Health Care, and United HealthCare. Note that fees for personal physicians, specialists, and private duty nurses might not be included in the hospital's billing. Island Health also accepts various insurances, such as Aetna, Cigna, Kaiser Permanente, Medicare, and United Healthcare.
What awards or recognition has Rhode Island Hospital received?
Rhode Island Hospital, located in Providence, Rhode Island, is a distinguished facility recognized for its excellence in research and care. It has been named a Blue Distinction Center for both Cancer Care and Cardiac Care by the Blue Cross Blue Shield Association. The hospital is also notable for ranking 13th among independent hospitals in National Institutes of Health funding, receiving over $27 million annually, and has earned the Get With The Guidelines-Stroke Gold Plus award from the American Heart Association/American Stroke Association, including honors in Stroke Elite Plus, Stroke Advanced Therapy, and Type 2 Diabetes.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.